Steven Chan, MD: How New Technologies are Changing Physician Practice
New technologies are creating opportunities for physicians to provide better treatment and differentiate themselves in a crowded health care space.
George Grossberg, MD: How Concussive Injuries Increase Risk of Alzheimer's
Physicians should remain vigilant in counseling their patients away from activities that pose a high risk of head injuries.
Fred Volkmar, MD: How Children with Autism See the World Differently
Our understanding of autism has improved significantly over the past decade. Among several discoveries, we now know that children with autism interpret faces differently than their peers without the condition.
Manisha Madhoo, MD: What is Mydayis?
In response to patient concerns about dosing options and duration of effect, researchers at Shire Pharmaceuticals created Mydayis for the treatment of ADHD symptoms.
Fred R Volkmar, MD: How Our Understanding of Autism Has Evolved
Over the last decade, physicians have gained significant ground in their understanding of autism. Here's what we know now.
Charles L Raison, MD: A History of Psychedelics in Psychiatry
Psychedelics like psilocybin have been receiving attention from psychiatrists on and off for decades. Here's what we've learned, and what's on the horizon.
Adult ADHD Patients Want Longer Acting Medications
When asked about an ideal medication, most survey respondents said such a drug would last all day.
Vladimir Maletic, MD: How Early Life Adversity Affects Mental Health
Parental rejection, abandonment, physical and sexual abuse double the victim's rates of depression, inflammation, metabolic disorders and chronic medical illnesses.
Arwen Podesta, MD: Best Practices for Treating Patients Addicted to Opioids
Patients struggling with addiction can be difficult to treat. Following best practices can help simplify a complex process.
Michael Thase, MD: How Managing Side Effects Improves Treatment Adherence
Patients ask about side effects a lot, but physicians aren't always keen to listen, according to Michael Thase, MD. Here's why they should.
Michael Thase, MD: Can Ketamine Curb Depression?
Ketamine shows huge promise in patients with depression. Here's why it may become the next big breakthrough treatment option in depressed patients.
Switching to Aripiprazole Lauroxil Improves Schizophrenia Symptoms in Phase 4 Study
The drug showed improved symptoms across multiple doses in a 6-month study.
Charles L Raison, MD: How the Connection Between the Brain and Bacteria Impacts the Clinical Setting
Doctors should be asking questions about their patients eating habits and gastrointestinal health when screening for mental illnesses, according to Dr Raison.
Kevin Hill, MD: 3 Key Conditions That Could be Treated with Cannabis
There are 3 key conditions that are likely to respond well to treatment with cannabis, with many more likely to be uncovered as research increases.
Kevin Hill, MD: New Opportunities Created by Changing Cannabis Policies
Kevin Hill, MD, explains how changing cannabis policies will open new doors for clinicians.
Charles L Raison, MD: What's Next for the Study of Microbiota?
Our understanding of the connection between the mind and microbiota has come a long way, but it still has a long way to go, according to Charles L Raison, MD.
Michael Thase, MD: Pharmacological Interventions Versus Therapy in Depressed Patients
Michael Thase, MD, explains the decision making process behind choosing drugs or therapy for patients with different types of depression.
Doris Greenberg, MD: What's the Difference Between Asperger's and Autism?
Doris Greenberg, MD, discusses the fine line between Asperger's Syndrome and Autism Spectrum Disorder.
Charles L Raison, MD: How Gut Microbiota Can Affect Mental Health
Charles L Raison, MD, explains the relationship between mental health and the trillions of microorganisms that live in and on our bodies.
